What Region Is Most Associated with Fracture-Associated Prescription Drug Use?
Many commonly prescribed drugs—such as some sleep aids—are known to carry an increased risk of breaking a bone, by increasing falls, weakening bones, or both.
Category: Prescription Drugs
Prescription Drugs
Latest
Prescription Drugs
Latest
Insomnia Patient Survey Offers Some Answers on Prescription Drug Use
Health Union, which creates condition-specific online patient communities, shared results from its Sleep Disorders In America survey.
Prescription Drugs
Popular
Narcolepsy May Not Look the Way You Would Expect
Narcolepsy, a relatively rare and poorly understood neurological condition, can be hard to diagnose. Julea Steiner was misdiagnosed for years before a sleep study helped doctors recognize her symptoms—excessive daytime sleepiness, vivid dreams, hallucinations, and mild cataplexy—as narcolepsy.
Large Study Finds Narcolepsy Drug Does Not Up Risk of Fetal Malformation
A registry study involving 2 million pregnant women shows no association between modafinil and an increased risk of malformation in babies.
Read MoreJazz Presents New Data on Xywav & Sunosi at Virtual SLEEP 2020
Highlights include presentations on Xywav, a lower sodium oxybate iindicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
Read MoreHarmony Presents New WAKIX Data at Virtual SLEEP 2020
The data include a final analysis of the Pitolisant Expanded Access Clinical Evaluation Program, two post-hoc analyses on clinically relevant outcomes from the Phase 3 clinical trials, and analyses that further characterize the cardiac safety profile of WAKIX.
Read MoreEisai Presents Latest Insomnia Research at Virtual SLEEP 2020
Highlights include an oral presentation focusing on the long-term efficacy and safety of DAYVIGO in adults ages 65 and older with insomnia disorder from the Phase 3 clinical study.
Read More
Ambien Dosage for Women Adjusted in 2013, But Sex Bias in Drug Trials Persists to This Day
New findings confirm the persistence of a drug dose gender gap stemming from a historic disregard of the biological differences between male and female bodies.
Read More
Benzodiazepines for Sleep Are Frequently Prescribed to Elderly at Hospital Discharge. New Prospective Cohort Study Links Them to Adverse Events.
Patients are vulnerable in the period after discharge, when risks and adverse reactions can result in ER visits, rehospitalization, and even death within 30 days.
Read More
A Newly Available Drug for Insomnia Addresses Both Sleep Onset and Maintenance
DAYVIGO targets orexin receptors to facilitate sleep. It’s been trialed in the elderly and in patients with common comorbidities.
Read More
FDA Approves Low Sodium Narcolepsy Oral Solution
Marketed by Jazz Pharmaceuticals, Xywav is for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older with narcolepsy.
Read MoreIn France, Zolpidem Prescriptions Down After Secure Prescribing Form Rule Implemented
This decline was partially compensated for by a rise in the use of a nonbenzodiazepine drug called zopiclone.
Read MoreHow To Know If You’re Relying Too Much On Sleep And Anxiety Medications
Benzodiazepines and prescription sleep aids should not be the first resort and they are not meant for long-term, emphasizes Lifehacker Australia.
Read More
Wakix Efficacy and Safety Abstracts Available on AAN’s Science Highlights Virtual Platform
“These data on the efficacy and safety of WAKIX strengthen the body of scientific evidence that supports WAKIX as a potential treatment option for adult patients living with narcolepsy.”
Read More
Insomnia Medication Prescriptions Increase with Spread of Coronavirus
Research from Express Scripts reveals the coronavirus is making a significant impact on mental health.
Read MorePaper Reviews Mechanisms of Action of Medications for Narcolepsy
Sleep Medicine has published an article that reviews the mechanism of action of available treatments for patients with narcolepsy.
Read MoreSolriamfetol Improves Quality of Life in People With Narcolepsy
Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, offers short-term improvements in health-related quality of life (HRQoL), and work productivity in people with narcolepsy, according to study results published in Sleep Medicine.
Read MoreIs the Antidepressant Trazodone Safe for Insomnia Patients?
The antidepressant trazodone is commonly prescribed to treat insomnia. An article by Consumer Reports looks into the safety of this practice. A handful of studies have shown that trazodone may improve sleep during the first...
Read More